Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Healthcare Cloud Infrastructure Market Size Worth $142.0 Billion By 2028: Grand View Research, Inc.


SAN FRANCISCO, Jan. 20, 2022 /PRNewswire/ -- The global healthcare cloud infrastructure market size is expected to reach USD 142.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.7% from 2021 to 2028. The growing trend of healthcare digitalization, rising expenditures, overburdened health systems, rising traffic on the network, growing data siloes, and the emergence of remote working is contributing to the demand for healthcare cloud infrastructure systems and solutions. Organizations are rapidly adopting hybrid cloud models to integrate several operations and functions in a multi-cloud environment to improve facility management. These advanced computing solutions allow organizations to safely and securely manage data and deliver optimum care with enhanced operational & clinical outcomes.

Grand_View_Research_Logo

Key Insights & Findings from the report:

Read 100 page market research report, "Healthcare Cloud Infrastructure Market Size, Share & Trends Analysis Report By Component (Hardware, Services), By End Use, By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028", by Grand View Research

The Covid-19 pandemic exposed the shortcomings of the overburdened health systems, reaffirmed the need to adopt advanced computing systems and several other advanced IT technological solutions to pave their path towards digitalization. These solutions allow organizations to optimize workflows, improve resource management, enhance cost optimization, efficient handling of growing network traffic, and risk mitigation. Key players are constantly devising their merger & acquisition and collaboration strategies to align their research & development goals to further innovate and expand their product portfolios.

The services segment dominated the market due to the easy accessibility of outsourcing these services from vendors since healthcare organizations lack the required technology skillset and expertise. Advanced computing systems provide these organizations with enhanced scalability, flexibility, and secure data management, which positively impacts the market growth. The available services in the cloud infrastructure market are Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), and Platform-as-a-Service (PaaS). However, the hardware segment is expected to grow significantly over the forecast period owing to the rising demand for hardware platforms with high computing power.

However, care providers dominated the end-use segment in 2020 owing to benefits offered by advanced computing systems such as secure off-site data collection & management, availability of outsourcing of IT solutions. However, the payer's segment is anticipated to record the fastest growth rate owing to the rising adoption of advanced computing systems in risk assessment, fraud detection, secure data collection & storage, and claims settlement. North America dominated due to the presence of advanced IT infrastructure, increased IT spending, and the large presence of key market players. The emergence of specialized start-ups in the Asia Pacific region is expected to further drive market growth.

Market Segmentation:

Grand View Research, has segmented the global healthcare cloud infrastructure market on the basis of component, end use, and region:

List of Key Players in Healthcare Cloud Infrastructure Market

Check out more studies form Grand View Research's portfolio on the Global Healthcare IT Industry:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: